What is the Current Share Price of Glenmark Pharmaceuticals Ltd?
- Answer Field
-
Glenmark Pharmaceuticals Ltd share price is for NSE ₹ 2,174.00 & for BSE ₹ 2,173.55 as on Jun 03 2026 03:29 PM.
Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply
GLENMARK PHARMACEUTICALS LTD. is currently trading at ₹2166, down by ₹18.89 from the previous close. The stock touched an intraday high of ₹2221.35 and a low of ₹2147.10 during the latest trading session. Over the past one year, GLENMARK PHARMACEUTICALS LTD. has delivered a return of 45.96%, while the stock has declined 8.68% in the last one month.
| Particulars | MAR 2026 (Values in Cr) |
|---|---|
| Revenue | 2207.56 |
| Operating Expense | 2193.08 |
| Net Profit | -73.90 |
| Net Profit Margin (%) | -3.34 |
| Earnings Per Share (EPS) | -2.62 |
| EBITDA | -29.36 |
| Effective Tax Rate (%) | 31.19 |
| Company Name | Price | P/E | P/B | Market Cap | 52 Week Low | 52 Week High |
|---|---|---|---|---|---|---|
| AMBALAL SARABHAI ENT L | 37.20 | 15.37 | 1.80 | 285.08 | 23.12 | 38.85 |
| BLISS GVS PHARMA LTD | 434.75 | 35.17 | 3.85 | 4599.18 | 118.35 | 442.20 |
| CIPLA LTD | 1378.90 | 27.30 | 3.23 | 111387.62 | 1165.55 | 1672.20 |
| FERMENTA BIOTECH LIMITED | 313.40 | 13.82 | 2.26 | 922.37 | 256.40 | 399.00 |
| Company Name | Price | P/E | P/B | Market Cap | 52 Week Low | 52 Week High |
|---|---|---|---|---|---|---|
| AMBALAL SARABHAI ENT L | 37.20 | 26.01 | 4.79 | 285.08 | 23.12 | 38.85 |
| AMRUTANJAN HEALTH CARE LTD. | 555.05 | 24.88 | 4.33 | 1604.68 | 490.00 | 789.95 |
| ASTRAZENECA PHARMA INDIA LTD. | 8719.05 | 113.87 | 24.97 | 21797.63 | 7630.00 | 10653.05 |
| BLISS GVS PHARMA LTD | 434.75 | 46.75 | 3.98 | 4599.18 | 118.35 | 442.20 |
Choose a Plan That Suits Your Goals and Needs
Freedom Pack
Subscription Charge : FREE
Professional Pack
Subscription Fee : ₹2,500 Yearly
Signature
Account Opening : FREE
*Note: The Freedom Pack is free for the first year and has an annual fee of ₹431 from the second year onwards.
| Particulars | Sep 2024 (Values in Cr) | Jun 2024 (Values in Cr) | Mar 2024 (Values in Cr) | Sep 2023 (Values in Cr) |
|---|---|---|---|---|
| Revenue | ₹2594.89 | ₹2296.88 | ₹7649.76 | ₹2170.40 |
| Operating Expense | ₹1924.12 | ₹1766.87 | ₹7128.73 | ₹1897.96 |
| Net Profit | ₹595.06 | ₹453.73 | ₹5167.29 | ₹302.35 |
| Net Profit Margin | 22.93% | 19.75% | 67.54% | 13.93% |
| Earnings Per Share | ₹21.09 | ₹16.08 | ₹183.13 | ₹10.72 |
| EBITDA | ₹861.70 | ₹686.75 | ₹7480.01 | ₹497.41 |
| Effective Tax Rate | 25.15% | 26.61% | 26.18% | 22.34% |
Key Highlights
| Particulars | Mar 2024 (Values in Cr) |
|---|---|
| Revenue | ₹7649.76 |
| Operating Expense | ₹7128.73 |
| Net Profit | ₹5167.29 |
| Net Profit Margin | 67.54% |
| Earnings Per Share | ₹183.13 |
| EBITDA | ₹7480.01 |
| Effective Tax Rate | 26.18% |
Key Highlights
| Ex-Date | Dividend Amount (₹) | Dividend Type | Record Date | Instrument Type |
|---|---|---|---|---|
| 18 Sep, 2023 | 2.5 | Final | 19 Sep, 2023 | Equity shares |
Key Highlights
1. Who is the CEO of Glenmark Pharmaceuticals Ltd?
The current CEO of Glenmark Pharmaceuticals Ltd is Glenn Saldanha, who is also the Chairman and Managing Director of the company. He has been a key figure in shaping the growth and success of Glenmark since its inception in 1977, leading its transformation into a global pharmaceutical player.
2. When was Glenmark Pharmaceuticals Ltd established?
Glenmark Pharmaceuticals Ltd was established on November 18, 1977. Since then, it has grown significantly, expanding its operations in various therapeutic areas and becoming a prominent player in the global pharmaceutical industry.
3. What factors influence the Glenmark Share Price?
Several factors influence the Glenmark share price, including the company's financial performance, new product launches, regulatory approvals, global market expansion, and developments in their R&D pipeline, particularly in the oncology, respiratory, and dermatology sectors. Market sentiment and broader economic conditions also play a critical role.
4. Is Glenmark Pharmaceuticals Ltd debt-free?
No, Glenmark Pharmaceuticals Ltd is not completely debt-free. As of March 2024, its consolidated debt stands at INR 9.9 billion, a reduction from higher amounts in previous years. The company is actively working towards prepaying most of its long-term debt using proceeds from the sale of its API business while maintaining a solid liquidity profile.
5. What is the CAGR of Glenmark Share?
The Compound Annual Growth Rate (CAGR) of Glenmark share price is as follows:
This reflects significant growth in recent years, particularly driven by strong performance in key therapeutic areas.
6. How has the Glenmark Share Price performed over the past year?
The Glenmark share price has surged by approximately 95.23% over the past year, with a 52-week high of ₹1,830.05 and a low of ₹764.25. While the stock has experienced slight declines in recent months—with returns of -10.65% over the past three months and -8.45% over the last month—the overall long-term outlook remains positive, with analysts giving it a "Buy" rating.
Glenmark Pharmaceuticals Ltd share price is for NSE ₹ 2,174.00 & for BSE ₹ 2,173.55 as on Jun 03 2026 03:29 PM.
The market cap of Glenmark Pharmaceuticals Ltd for NSE ₹ 0.00 & for BSE ₹ 61,337.80 as on Jun 03 2026 03:29 PM.
The 52 Week High and Low of Glenmark Pharmaceuticals Ltd for NSE is ₹ 2,474.00 and ₹ 1,448.50 and for BSE is ₹ 2,471.05 and ₹ 1,448.50.
The 1 year returns on the stock has been 45.96%.
As on Jun 03 2026 03:29 PM the price-to-earnings (PE) ratio for Glenmark Pharmaceuticals Ltd share is -306.87.
As on Jun 03 2026 03:29 PM, the price-to-book (PB) ratio for Glenmark Pharmaceuticals Ltd share is 855.78.
You can trade in Glenmark Pharmaceuticals Ltd shares with Bajaj Broking by opening a demat account.
To buy Glenmark Pharmaceuticals Ltd shares on the Bajaj Broking app, follow these steps:
• Login to the Bajaj Broking App
• Click on the Search Icon
• Search “Glenmark Pharmaceuticals Ltd”
• Click on the BUY icon
• Place a buy order specifying the desired quantity of shares.
• Click BUY again to complete the purchase
No results found